Skip to main content
Top
Gepubliceerd in: Mednet 7/2014

01-11-2014 | Mednet | CME

Erfelijke hartziekte hypertrofische cardiomyopathie

CME Cardiogenetica

Auteur: Bohn Stafleu van Loghum

Gepubliceerd in: Mednet | Uitgave 7/2014

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

De meest voorkomende erfelijk bepaalde hartziekte is hypertrofische cardiomyopathie (HMC). Hoe groot is de kans dat een patiënt in uw huisartsenpraktijk erfelijk is belast? Hoe bepaalt u wanneer u moet doorverwijzen en hoe is vervolgens de behandeling? Dit artikel, dat in langere vorm is verschenen in het NTvG, geeft meer informatie over het ziektebeeld en genetische screening en is onderdeel van de module Mednet CME: erfelijke hart- en vaatziekten in de familie: acute hartdood in de familie.
Literatuur
1.
go back to reference Keren A, Syrris P, McKenna WJ. Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression. Nat Clin Pract Cardiovasc Med. 2008;5:158–68.PubMedCrossRef Keren A, Syrris P, McKenna WJ. Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression. Nat Clin Pract Cardiovasc Med. 2008;5:158–68.PubMedCrossRef
2.
go back to reference Elliot P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, et al. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2008;29:270–6CrossRef Elliot P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, et al. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2008;29:270–6CrossRef
3.
go back to reference Maron BJ, Casey SA, Hauser RG, Aeppli DM. Clinical course of hypertrophic cardiomyopathy with survival to advanced age. J Am Coll Cardiol. 2003;42:882–8.PubMedCrossRef Maron BJ, Casey SA, Hauser RG, Aeppli DM. Clinical course of hypertrophic cardiomyopathy with survival to advanced age. J Am Coll Cardiol. 2003;42:882–8.PubMedCrossRef
4.
go back to reference Maron MS, Olivotto I, Zenovich AG, Link MS, Pandian NG, Kuvin JT, et al. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation. 2006;114:2232–9.PubMedCrossRef Maron MS, Olivotto I, Zenovich AG, Link MS, Pandian NG, Kuvin JT, et al. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation. 2006;114:2232–9.PubMedCrossRef
5.
go back to reference Olivotto I, Cecchi F, Casey SA, Dolara A, Traverse JH, Maron BJ. Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation. 2001;104:2517–24.PubMedCrossRef Olivotto I, Cecchi F, Casey SA, Dolara A, Traverse JH, Maron BJ. Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation. 2001;104:2517–24.PubMedCrossRef
6.
go back to reference Corrado D, Basso C, Pavei A, Michieli P, Schiavon M, Thiene G. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA. 2006;296:1593–601.PubMedCrossRef Corrado D, Basso C, Pavei A, Michieli P, Schiavon M, Thiene G. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA. 2006;296:1593–601.PubMedCrossRef
8.
go back to reference Elliot P, McKenna WJ. Hypertrophic cardiomyopathy. Lancet. 2004;363:1881–91CrossRef Elliot P, McKenna WJ. Hypertrophic cardiomyopathy. Lancet. 2004;363:1881–91CrossRef
9.
go back to reference Van Driest SL, Ommen SR, Tajik AJ, Gersh BJ, Ackerman MJ. Sarcomeric genotyping in hypertrophic cardiomyopathy. Mayo Clin Proc. 2005;80:463–9.PubMedCrossRef Van Driest SL, Ommen SR, Tajik AJ, Gersh BJ, Ackerman MJ. Sarcomeric genotyping in hypertrophic cardiomyopathy. Mayo Clin Proc. 2005;80:463–9.PubMedCrossRef
10.
go back to reference Maron BJ, Chaitman BR, Ackerman MJ, Bayes de Lunca A, Corrado D, Crosson JE, et al. Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation. 2004;109:2807–16PubMedCrossRef Maron BJ, Chaitman BR, Ackerman MJ, Bayes de Lunca A, Corrado D, Crosson JE, et al. Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation. 2004;109:2807–16PubMedCrossRef
11.
go back to reference Ommen SR, Shah PM, Tajik AJ. Left ventricular outflow tract obstruction in hypertrophic cardiomyopathy: past, present and future. Heart. 2008;94:1276–81.PubMedCrossRef Ommen SR, Shah PM, Tajik AJ. Left ventricular outflow tract obstruction in hypertrophic cardiomyopathy: past, present and future. Heart. 2008;94:1276–81.PubMedCrossRef
12.
go back to reference Elliott P, Spirito P. Prevention of hypertrophic cardiomyopathy-related deaths: theory and practice. Heart. 2008;94:1269–75.PubMedCrossRef Elliott P, Spirito P. Prevention of hypertrophic cardiomyopathy-related deaths: theory and practice. Heart. 2008;94:1269–75.PubMedCrossRef
13.
go back to reference Elliott PM, Poloniecki J, Dickie S, Sharma S, Monserrat L, Varnava A, et al. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol. 2000;36:2212–8.PubMedCrossRef Elliott PM, Poloniecki J, Dickie S, Sharma S, Monserrat L, Varnava A, et al. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol. 2000;36:2212–8.PubMedCrossRef
14.
go back to reference Christiaans I, Lekanne dit Deprez RH, van Langen IM, Wilde AA. Ventricular fibrillation in MYH7-related hypertrophic cardiomyopathy before onset of ventricular hypertrophy. Hearth Rhythm. 2009;6:1366–9.CrossRef Christiaans I, Lekanne dit Deprez RH, van Langen IM, Wilde AA. Ventricular fibrillation in MYH7-related hypertrophic cardiomyopathy before onset of ventricular hypertrophy. Hearth Rhythm. 2009;6:1366–9.CrossRef
15.
go back to reference Christiaans I, Birnie E, Bonsel GJ, Wilde AA, van Langen IM. Uptake of genetic counselling and predictive DNA testing in hypertrophic cardiomyopathy. Eur J Hum Genet. 2008;16:1201–7.PubMedCrossRef Christiaans I, Birnie E, Bonsel GJ, Wilde AA, van Langen IM. Uptake of genetic counselling and predictive DNA testing in hypertrophic cardiomyopathy. Eur J Hum Genet. 2008;16:1201–7.PubMedCrossRef
Metagegevens
Titel
Erfelijke hartziekte hypertrofische cardiomyopathie
CME Cardiogenetica
Auteur
Bohn Stafleu van Loghum
Publicatiedatum
01-11-2014
Uitgeverij
Bohn Stafleu van Loghum
Gepubliceerd in
Mednet / Uitgave 7/2014
Print ISSN: 1568-7716
Elektronisch ISSN: 1876-5963
DOI
https://doi.org/10.1007/s12462-014-0210-4

Andere artikelen Uitgave 7/2014

Mednet 7/2014 Naar de uitgave